TScan Therapeutics, Inc. Common Stock (TCRX) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for TCRX. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 57 institutions reported holding TCRX, with 35.8 million shares worth $35.1 million in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Lynx1 Capital Management | 8,019,148 | $8M | UNCHANGED |
| Bvf Inc/IL | 5,564,290 | $5M | UNCHANGED |
| Baker Bros. Advisors | 2,784,792 | $3M | UNCHANGED |
| Vanguard | 2,556,449 | $3M | INCREASED |
| Two Sigma Investments | 1,949,604 | $2M | INCREASED |
Full institutional holdings, insider history, and congressional trades for TScan Therapeutics, Inc. Common Stock on SentiSense.